Bieth, Bruno,Burkhart, Christoph,Christ, Andreas,De Buck, Stefan,Kalis, Christoph,Lindgren, Sam
申请号：
HRP20200916
公开号：
HRP20200916T1
申请日:
2020.06.08
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
The invention relates to the use of 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one or pharmaceutically acceptable salts thereof for the treatment of primary Sjögren's Syndrome.
